{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:40:55Z","timestamp":1759981255191,"version":"build-2065373602"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,8]]},"DOI":"10.7759\/cureus.94159","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:19:06Z","timestamp":1759979946000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes"],"prefix":"10.7759","author":[{"given":"Khalid","family":"Sawalha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Alamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Fancher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munes","family":"Albadaineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Lopez-Candales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Asif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000039105.49749.6f","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones DM","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP, et al.. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002, 106:3068-72. 10.1161\/01.cir.0000039105.49749.6f","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber Y","year":"2015","unstructured":"Gerber Y, Weston SA, Redfield MM, et al.. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015, 175:996-1004. 10.1001\/jamainternmed.2015.0924","journal-title":"JAMA Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao CW","year":"2018","unstructured":"Tsao CW, Lyass A, Enserro D, et al.. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 2018, 6:678-85. 10.1016\/j.jchf.2018.03.006","journal-title":"JACC Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al.. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020, 141:e139-596. 10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah KS","year":"2017","unstructured":"Shah KS, Xu H, Matsouaka RA, et al.. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017, 70:2476-86. 10.1016\/j.jacc.2017.08.074","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, et al.. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021, 23:352-80. 10.1002\/ejhf.2115","journal-title":"Eur J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium","volume":"22","author":"Abraham WT","year":"2020","unstructured":"Abraham WT, Psotka MA, Fiuzat M, et al.. Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium. Eur J Heart Fail. 2020, 22:2175-86. 10.1002\/ejhf.2018","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson MM","year":"2023","unstructured":"Kittleson MM, Panjrath GS, Amancherla K, et al.. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023, 81:1835-78. 10.1016\/j.jacc.2023.03.393","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3310\/hta13320","article-title":"Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care","volume":"13","author":"Mant J","year":"2009","unstructured":"Mant J, Doust J, Roalfe A, et al.. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009, 13:1-207, iii. 10.3310\/hta13320","journal-title":"Health Technol Assess"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-014-0501-8","article-title":"Heart failure with preserved ejection fraction: current understandings and challenges","volume":"16","author":"Andersen MJ","year":"2014","unstructured":"Andersen MJ, Borlaug BA. Heart failure with preserved ejection fraction: current understandings and challenges. Curr Cardiol Rep. 2014, 16:501. 10.1007\/s11886-014-0501-8","journal-title":"Curr Cardiol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","author":"Reddy YN","year":"2016","unstructured":"Reddy YN, Borlaug BA. Heart failure with preserved ejection fraction. Curr Probl Cardiol. 2016, 41:145-88. 10.1016\/j.cpcardiol.2015.12.002","journal-title":"Curr Probl Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.1916","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"7","author":"Reddy YN","year":"2022","unstructured":"Reddy YN, Kaye DM, Handoko ML, et al.. Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea. JAMA Cardiol. 2022, 7:891-9. 10.1001\/jamacardio.2022.1916","journal-title":"JAMA Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.03.013","article-title":"Application of diagnostic algorithms for\u00a0heart\u00a0failure with preserved ejection\u00a0fraction to the community","volume":"8","author":"Selvaraj S","year":"2020","unstructured":"Selvaraj S, Myhre PL, Vaduganathan M, et al.. Application of diagnostic algorithms for\u00a0heart\u00a0failure with preserved ejection\u00a0fraction to the community. JACC Heart Fail. 2020, 8:640-53. 10.1016\/j.jchf.2020.03.013","journal-title":"JACC Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02922-7","article-title":"A network medicine approach to study comorbidities in heart failure with preserved ejection fraction","volume":"21","author":"Lanzer JD","year":"2023","unstructured":"Lanzer JD, Valdeolivas A, Pepin M, et al.. A network medicine approach to study comorbidities in heart failure with preserved ejection fraction. BMC Med. 2023, 21:267. 10.1186\/s12916-023-02922-7","journal-title":"BMC Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella GG","year":"2021","unstructured":"Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res. 2021, 117:423-34. 10.1093\/cvr\/cvaa217","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307787","article-title":"From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress","volume":"102","author":"Franssen C","year":"2016","unstructured":"Franssen C, Chen S, Hamdani N, Paulus WJ. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress. Heart. 2016, 102:320-30. 10.1136\/heartjnl-2015-307787","journal-title":"Heart"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile MR","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004, 350:1953-9. 10.1056\/NEJMoa032566","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.05.012","article-title":"Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency","volume":"54","author":"Phan TT","year":"2009","unstructured":"Phan TT, Abozguia K, Nallur Shivu G, et al.. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol. 2009, 54:402-9. 10.1016\/j.jacc.2009.05.012","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.716886","article-title":"Role of left ventricular stiffness in heart failure with normal ejection fraction","volume":"117","author":"Westermann D","year":"2008","unstructured":"Westermann D, Kasner M, Steendijk P, et al.. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008, 117:2051-60. 10.1161\/CIRCULATIONAHA.107.716886","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.076","article-title":"Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis","volume":"55","author":"Penicka M","year":"2010","unstructured":"Penicka M, Bartunek J, Trakalova H, Hrabakova H, Maruskova M, Karasek J, Kocka V. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis. J Am Coll Cardiol. 2010, 55:1701-10. 10.1016\/j.jacc.2009.11.076","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.867044","article-title":"Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction","volume":"3","author":"Prasad A","year":"2010","unstructured":"Prasad A, Hastings JL, Shibata S, et al.. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail. 2010, 3:617-26. 10.1161\/CIRCHEARTFAILURE.109.867044","journal-title":"Circ Heart Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.123","article-title":"The many faces of heart failure with preserved ejection fraction","volume":"9","author":"Shah AM","year":"2012","unstructured":"Shah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2012, 9:555-6. 10.1038\/nrcardio.2012.123","journal-title":"Nat Rev Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:17:2","article-title":"Haemodynamics of heart failure with preserved ejection fraction: a clinical perspective","volume":"2","author":"Gori M","year":"2016","unstructured":"Gori M, Iacovoni A, Senni M. Haemodynamics of heart failure with preserved ejection fraction: a clinical perspective. Card Fail Rev. 2016, 2:102-5. 10.15420\/cfr.2016:17:2","journal-title":"Card Fail Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay SM","year":"2019","unstructured":"Dunlay SM, Givertz MM, Aguilar D, et al.. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019, 140:e294-324. 10.1161\/CIR.0000000000000691","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart\u00a0failure with preserved ejection\u00a0fraction: JACC scientific statement","volume":"81","author":"Borlaug BA","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart\u00a0failure with preserved ejection\u00a0fraction: JACC scientific statement. J Am Coll Cardiol. 2023, 81:1810-34. 10.1016\/j.jacc.2023.01.049","journal-title":"J Am Coll Cardiol"},{"key":"ref26","article-title":"Heart failure with preserved ejection fraction (HFpEF)","author":"Golla MS","year":"2024","unstructured":"Golla MS, Shams P. Heart failure with preserved ejection fraction (HFpEF). StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging","volume":"29","author":"Nagueh SF","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging. J Am Soc Echocardiogr. 2016, 29:277-314. 10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan TE","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355:251-9. 10.1056\/NEJMoa052256","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield MM","year":"2016","unstructured":"Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2016, 375:1868-77. 10.1056\/NEJMcp1511175","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy YN","year":"2018","unstructured":"Reddy YN, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018, 138:861-70. 10.1161\/CIRCULATIONAHA.118.034646","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske B","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al.. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019, 40:3297-317. 10.1093\/eurheartj\/ehz641","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2019","article-title":"The HFA-PEFF and H(2) FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction","volume":"23","author":"Sanders-van Wijk S","year":"2021","unstructured":"Sanders-van Wijk S, Barandiar\u00e1n Aizpurua A, Brunner-La Rocca HP, et al.. The HFA-PEFF and H(2) FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction. Eur J Heart Fail. 2021, 23:838-40. 10.1002\/ejhf.2019","journal-title":"Eur J Heart Fail"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14421","article-title":"Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta-analysis","volume":"10","author":"Li S","year":"2023","unstructured":"Li S, Zhu X, Zhang Y, Li F, Guo S. Validation of heart failure algorithm for diagnosing heart failure with preserved ejection fraction: a meta-analysis. ESC Heart Fail. 2023, 10:2225-35. 10.1002\/ehf2.14421","journal-title":"ESC Heart Fail"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.01.015","article-title":"Utility and validity of the HFA-PEFF and\u00a0H(2)FPEF scores in patients with symptomatic atrial fibrillation","volume":"12","author":"Ariyaratnam JP","year":"2024","unstructured":"Ariyaratnam JP, Mishima RS, Kadhim K, et al.. Utility and validity of the HFA-PEFF and\u00a0H(2)FPEF scores in patients with symptomatic atrial fibrillation. JACC Heart Fail. 2024, 12:1015-25. 10.1016\/j.jchf.2024.01.015","journal-title":"JACC Heart Fail"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","author":"Nativi-Nicolau JN","year":"2022","unstructured":"Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. 2022, 27:785-93. 10.1007\/s10741-021-10080-2","journal-title":"Heart Fail Rev"},{"key":"ref36","unstructured":"American College of Cardiology. 2023 ACC expert consensus on management of HFpEF: key points. (2023). Accessed: October 9, 2025: https:\/\/www.acc.org\/Latest-in-Cardiology\/ten-points-to-remember\/2023\/04\/17\/16\/40\/2023-acc-expert-consensus-on-hfpef."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-021-00904-7","article-title":"Invasive hemodynamic and metabolic evaluation of HFpEF","volume":"23","author":"Finet JE","year":"2021","unstructured":"Finet JE, Van Iterson EH, Wilson Tang WH. Invasive hemodynamic and metabolic evaluation of HFpEF. Curr Treat Options Cardiovasc Med. 2021, 23:32. 10.1007\/s11936-021-00904-7","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.10.016","article-title":"The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Lancellotti P","year":"2017","unstructured":"Lancellotti P, Pellikka PA, Budts W, et al.. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017, 30:101-38. 10.1016\/j.echo.2016.10.016","journal-title":"J Am Soc Echocardiogr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.08.017","article-title":"Novel recommendations for the treatment of patients with heart failure: 2023 focused update of the 2021 ESC heart failure guidelines","volume":"29","author":"Voors AA","year":"2023","unstructured":"Voors AA. Novel recommendations for the treatment of patients with heart failure: 2023 focused update of the 2021 ESC heart failure guidelines. J Card Fail. 2023, 29:1667-71. 10.1016\/j.cardfail.2023.08.017","journal-title":"J Card Fail"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2118470","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"386","author":"Amato J Jr","year":"2022","unstructured":"Amato J Jr. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2022, 386:e57. 10.1056\/NEJMc2118470","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-022-05123-9","article-title":"Comorbidities in heart failure with preserved ejection fraction","volume":"47","author":"Deichl A","year":"2022","unstructured":"Deichl A, Wachter R, Edelmann F. Comorbidities in heart failure with preserved ejection fraction. Herz. 2022, 47:301-7. 10.1007\/s00059-022-05123-9","journal-title":"Herz"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021165","article-title":"Validation of the 2016 ASE\/EACVI guideline for diastolic dysfunction in patients with unexplained dyspnea and a preserved left ventricular ejection fraction","volume":"10","author":"van de Bovenkamp AA","year":"2021","unstructured":"van de Bovenkamp AA, Enait V, de Man FS, et al.. Validation of the 2016 ASE\/EACVI guideline for diastolic dysfunction in patients with unexplained dyspnea and a preserved left ventricular ejection fraction. J Am Heart Assoc. 2021, 10:e021165. 10.1161\/JAHA.121.021165","journal-title":"J Am Heart Assoc"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2014.04.008","article-title":"Phenotypic spectrum of heart failure with preserved ejection fraction","volume":"10","author":"Shah SJ","year":"2014","unstructured":"Shah SJ, Katz DH, Deo RC. Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Fail Clin. 2014, 10:407-18. 10.1016\/j.hfc.2014.04.008","journal-title":"Heart Fail Clin"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1552826","article-title":"Heart failure with preserved left ventricular ejection fraction: a complex conundrum simply not limited to diastolic dysfunction","volume":"2023","author":"Lopez-Candales A","year":"2023","unstructured":"Lopez-Candales A, Asif T, Sawalha K, Norgard NB. Heart failure with preserved left ventricular ejection fraction: a complex conundrum simply not limited to diastolic dysfunction. Cardiovasc Ther. 2023, 2023:1552826. 10.1155\/2023\/1552826","journal-title":"Cardiovasc Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49178","article-title":"Obesity-induced hyperglycemia and heart failure preserved ejection fraction: uncharted territories to remission","volume":"15","author":"Sawalha K","year":"2023","unstructured":"Sawalha K, Asad O, Tadisina S, Alalawi L, Mahmood M, Alkhatib D, Alexander T. Obesity-induced hyperglycemia and heart failure preserved ejection fraction: uncharted territories to remission. Cureus. 2023, 15:e49178. 10.7759\/cureus.49178","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424195-improving-recognition-of-heart-failure-with-preserved-ejection-fraction-in-the-outpatient-setting-a-pilot-study-of-readily-useful-clinical-attributes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:19:09Z","timestamp":1759979949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424195-improving-recognition-of-heart-failure-with-preserved-ejection-fraction-in-the-outpatient-setting-a-pilot-study-of-readily-useful-clinical-attributes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.94159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}